163 related articles for article (PubMed ID: 16272356)
1. A mimic of p21WAF1/CIP1 ameliorates murine lupus.
Goulvestre C; Chéreau C; Nicco C; Mouthon L; Weill B; Batteux F
J Immunol; 2005 Nov; 175(10):6959-67. PubMed ID: 16272356
[TBL] [Abstract][Full Text] [Related]
2. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
3. CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity.
Lettesjö H; Burd GP; Mageed RA
J Immunol; 2000 Oct; 165(7):4095-104. PubMed ID: 11034421
[TBL] [Abstract][Full Text] [Related]
4. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
5. Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupus-like disease.
Liu SD; Lee S; La Cava A; Motran CC; Hahn BH; Miceli MC
Lupus; 2011 Apr; 20(5):473-84. PubMed ID: 21335401
[TBL] [Abstract][Full Text] [Related]
6. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
[TBL] [Abstract][Full Text] [Related]
7. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
8. Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages.
Zhang H; Fu R; Guo C; Huang Y; Wang H; Wang S; Zhao J; Yang N
J Transl Med; 2016 Jun; 14(1):156. PubMed ID: 27250627
[TBL] [Abstract][Full Text] [Related]
9. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
Starke C; Steinkasserer A; Voll RE; Zinser E
Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
[TBL] [Abstract][Full Text] [Related]
10. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
[TBL] [Abstract][Full Text] [Related]
11. The treatment of autoimmune disease in (NZB/NZW)F1 mice with syngeneic photomodulated splenocytes.
Lin RH; Wang LF
Scand J Immunol; 1994 May; 39(5):446-52. PubMed ID: 8191220
[TBL] [Abstract][Full Text] [Related]
12. CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus.
Mihara M; Tan I; Chuzhin Y; Reddy B; Budhai L; Holzer A; Gu Y; Davidson A
J Clin Invest; 2000 Jul; 106(1):91-101. PubMed ID: 10880052
[TBL] [Abstract][Full Text] [Related]
13. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.
Hahn BH; Singh RR; Wong WK; Tsao BP; Bulpitt K; Ebling FM
Arthritis Rheum; 2001 Feb; 44(2):432-41. PubMed ID: 11229475
[TBL] [Abstract][Full Text] [Related]
14. Induction of autoantibody production is limited in nonautoimmune mice.
Singh RR; Ebling FM; Albuquerque DA; Saxena V; Kumar V; Giannini EH; Marion TN; Finkelman FD; Hahn BH
J Immunol; 2002 Jul; 169(1):587-94. PubMed ID: 12077292
[TBL] [Abstract][Full Text] [Related]
15. Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly.
Santiago FS; Ishii H; Shafi S; Khurana R; Kanellakis P; Bhindi R; Ramirez MJ; Bobik A; Martin JF; Chesterman CN; Zachary IC; Khachigian LM
Circ Res; 2007 Jul; 101(2):146-55. PubMed ID: 17556661
[TBL] [Abstract][Full Text] [Related]
16. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
17. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus.
Kaliyaperumal A; Mohan C; Wu W; Datta SK
J Exp Med; 1996 Jun; 183(6):2459-69. PubMed ID: 8676066
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice.
Gu F; Molano I; Ruiz P; Sun L; Gilkeson GS
Clin Immunol; 2012 Nov; 145(2):142-52. PubMed ID: 23041504
[TBL] [Abstract][Full Text] [Related]
19. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
[TBL] [Abstract][Full Text] [Related]
20. Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice.
Trigunaite A; Khan A; Der E; Song A; Varikuti S; Jørgensen TN
Arthritis Rheum; 2013 Sep; 65(9):2392-402. PubMed ID: 23754362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]